Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis trial marks ResearchKit first in MS

ElevateMS study will allow participants to contribute from smartphones

Novartis MS smartphone Apple iPhone ResearchKit study

Novartis has launched the first large-scale research study in multiple sclerosis using Apple’s ResearchKit software.

Participants will be able to contribute directly from their smartphones, via sensors that will collect movement and symptom data, removing the need for clinic visits.

The US mobile-enabled study uses a free-to-download iPhone app that was built on Apple’s ResearchKit platform, software that’s already in use at companies such as GlaxoSmithKline and Celgene.

Novartis’ Evaluation of Evidence from Smart Phone Sensors and Patient-Reported Outcomes in Participants with Multiple Sclerosis, or elevateMS, study aims to improve understanding of patients’ daily challenges.

The Swiss pharma firm and its tech partner Sage Biosystems also hope real-time data collection will enable them to uncover new potential measurements of treatment effectiveness.

Stanley Cohan, medical director at Providence Multiple Sclerosis Center in Portland, Oregon, is a scientific advisor to the study.

He said: “As physicians, we always want to know how our patients with MS are doing on the treatments we prescribe.

“With the elevateMS app, study participants can frequently document their symptoms in a personal health story. In turn, this data may provide researchers with new ways to look at disease progression and treatment effectiveness.”

The elevateMS mobile app can be downloaded from the Apple App Store and offers users a range of activities, including brainteasers and questionnaires about their health, while taking measures from the iPhone’s built-in sensors.

The study is only open to adults in the US that own an iPhone (4s or newer model), but participants with and without MS can sign up to help researchers better understand what it’s like to live with the condition.

22nd August 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...